Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Nature Genetics

• Publication date

  1993-10-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/NG1193-230PMID 8275086
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma

  1993cited by this paper
• Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma

  1993cited by this paper
• Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma

  1993cited by this paper
• Transcriptional repression by the Drosophila even-skipped protein: definition of a minimal repression domain.

  1993cited by this paper
• Identification of a ten-amino acid proline-rich SH3 binding site.

  1993cited by this paper
• Differential expression of multiple fork head related genes during gastrulation and axial pattern formation in the mouse embryo.

  1993cited by this paper
• Identification of nine tissue-specific transcription factors of the hepatocyte nuclear factor 3/forkhead DNA-binding-domain family.

  1993cited by this paper
• The oncogenic potential of Pax genes.

  1993cited by this paper
• Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation.

  1993cited by this paper
• The retroviral oncogene qin belongs to the transcription factor family that includes the homeotic gene fork head.

  1993cited by this paper
• Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I).

  1993cited by this paper
• Telencephalon-restricted expression of BF-1, a new member of the HNF-3/fork head gene family, in the developing rat brain.

  1992cited by this paper
• Hepatocyte nuclear factor 3 beta contains two transcriptional activation domains, one of which is novel and conserved with the Drosophila fork head protein

  1992cited by this paper
• Developmentally regulated Drosophila gene family encoding the fork head domain.

  1992cited by this paper
• Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours

  1992cited by this paper
• The Drosophila sloppy paired locus encodes two proteins involved in segmentation that show homology to mammalian transcription factors.

  1992cited by this paper
• Localization of the t(2;13) breakpoint of alveolar rhabdomyosarcoma on a physical map of chromosome 2.

  1992cited by this paper
• Structural features in eukaryotic mRNAs that modulate the initiation of translation.

  1991cited by this paper
• Pax‐3, a novel murine DNA binding protein expressed during early neurogenesis.

  1991cited by this paper
• Hepatocyte nuclear factor 3 alpha belongs to a gene family in mammals that is homologous to the Drosophila homeotic gene fork head.

  1991cited by this paper
• The chromosomes in human cancer and leukemia

  1990cited by this paper
• Basic local alignment search tool.

  1990cited by this paper
• HNF-3A, a hepatocyte-enriched transcription factor of novel structure is regulated transcriptionally.

  1990cited by this paper
• The fork head domain: a novel DNA binding motif of eukaryotic transcription factors?

  1990cited by this paper
• Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins.

  1989cited by this paper
• Conservation of the paired domain in metazoans and its structure in three isolated human genes.

  1989cited by this paper
• The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo.

  1989cited by this paper
• Fos-associated protein p39 is the product of the jun proto-oncogene.

  1988cited by this paper
• Isolation of RNA using guanidinium salts.

  1987cited by this paper

• Dual-specificity phosphatase 6 interferes with the repressive activity of forkhead box O1 towards CYP4A11 that mediates lipid accumulation in the liver

  2026cites this paper
• LEP and FOXO1 genes, as a proposed tumor suppressor autophagic cell death related genes, can be targeted by antidiabetic therapy in nondiabetic breast cancer patients

  2025cites this paper
• DNA methylation patterns are influenced by Pax3 :: Foxo1 expression and developmental lineage in rhabdomyosarcoma tumours forming in genetically engineered mouse models

  2025cites this paper
• MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation

  2025cites this paper
• Primary Ocular, Adnexal, and Orbital Rhabdomyosarcoma: A Review.

  2025cites this paper
• Fusion transcription factor dosage controls cell state in rhabdomyosarcoma

  2025cites this paper
• Fusion oncogenes in rhabdomyosarcoma: model systems, mechanisms of tumorigenesis, and therapeutic implications

  2025cites this paper
• Ephrin-A5 or EphA7 stimulation is anti-proliferative for human rhabdomyosarcoma in vitro

  2025cites this paper
• Rhabdomyosarcoma fusion oncoprotein initially pioneers a neural signature in vivo

  2025cites this paper
• Transdifferentiation of endothelial progenitor cells into rhabdomyosarcoma defined by hedgehog signaling competence

  2025cites this paper
• T2-weighted MRI radiomics for the prediction of pediatric and young adult rhabdomyosarcoma alveolar subtype and distant metastasis: a pilot study

  2025cites this paper
• EHMT1 mediates cellular motility in embryonal rhabdomyosarcoma by activating SOX8 expression

  2025cites this paper
• Identification of a novel FOXO3‑associated prognostic model in hepatocellular carcinoma

  2025cites this paper
• Cancer-associated fibroblasts promote tumor progression in fusion-positive rhabdomyosarcoma

  2025cites this paper
• Myogenesis gone awry: the role of developmental pathways in rhabdomyosarcoma

  2025cites this paper
• Evaluation of Atypical FISH Findings by RNA Sequencing.

  2025cites this paper
• The role of FMO3 in metabolic diseases

  2024cites this paper
• FOXO1 promotes cancer cell growth through MDM2-mediated p53 degradation

  2024cites this paper
• SARCP, A Clinical Next Generation Sequencing Assay for the Detection of Gene Fusions in Sarcomas: A Description of the First 652 Cases.

  2024cites this paper
• Exploring the reciprocity between pioneer factors and development.

  2024cites this paper
• Botryoid-type Embryonal Rhabdomyosarcoma

  2024cites this paper
• Forkhead box O1 transcription factor; a therapeutic target for diabetic cardiomyopathy

  2024cites this paper
• FOXO1 induced fatty acid oxidation in hepatic cells by targeting ALDH1L2

  2024cites this paper
• Engineering an fgfr4 knockout zebrafish to study its role in development and disease

  2024cites this paper
• CRISPR-Cas9-Mediated Bioluminescent Tagging of Endogenous Proteins by Fluorescent Protein-Assisted Cell Sorting.

  2024cites this paper
• Developmental Heterogeneity of Rhabdomyosarcoma.

  2024cites this paper
• Sarcoma_CellminerCDB: A tool to interrogate the genomic and functional characteristics of a comprehensive collection of sarcoma cell lines

  2024cites this paper
• The PAX Genes: Roles in Development, Cancer, and Other Diseases

  2024cites this paper
• Biological and therapeutic insights from animal modeling of fusion-driven pediatric soft tissue sarcomas

  2024cites this paper
• PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors

  2023cites this paper
• CAR T cells recognizing CD276 and Dual-CAR T cells against CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models

  2023cites this paper
• Staufen1 controls mitochondrial metabolism via HIF2α in embryonal rhabdomyosarcoma and promotes tumorigenesis

  2023cites this paper
• CAR T cells recognizing CD276 and Dual-CAR T cells against CD276/FGFR4 promote rhabdomyosarcoma clearance in an orthotopic mouse model

  2023cites this paper
• Myo-differentiation reporter screen reveals NF-Y as an activator of PAX3–FOXO1 in rhabdomyosarcoma

  2023cites this paper
• A systematic review of the prevalence of pathogenic or likely pathogenic germline variants in individuals with FOXO1 fusion‐positive rhabdomyosarcoma

  2023cites this paper
• Rhabdomyosarcoma Arising in Inflammatory Rhabdomyoblastic Tumor: A Genetically Distinctive Subtype of Rhabdomyosarcoma.

  2023cites this paper
• Fusion genes aiding the diagnosis of soft tissue tumours of the oral cavity: from bench to bedside.

  2023cites this paper
• METTL3 Mediates Epithelial–Mesenchymal Transition by Modulating FOXO1 mRNA N6‐Methyladenosine‐Dependent YTHDF2 Binding: A Novel Mechanism of Radiation‐Induced Lung Injury

  2023cites this paper
• The discrete roles of individual FOXO transcription factor family members in B-cell malignancies

  2023cites this paper
• Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma

  2023influential citation
• BET Bromodomain Degradation Disrupts Function but Not 3D Formation of RNA Pol2 Clusters

  2023influential citation
• MicroRNAs in the Pathogenesis, Prognostication and Prediction of Treatment Resistance in Soft Tissue Sarcomas

  2023cites this paper
• Targeting SWI/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomas

  2023cites this paper
• CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models

  2023cites this paper
• Extensive analysis of 59 sarcoma‐related fusion genes identified pazopanib as a potential inhibitor to COL1A1‐PDGFB fusion gene

  2023cites this paper
• Rhabdomyosarcoma With Epithelioid Features And NSD3::FOXO1 Fusion: Evidence For Reconsideration Of Previously Reported FOXO1::FGFR1 Fusion

  2022cites this paper
• Rapid and highly sensitive approach for multiplexed somatic fusion detection

  2022cites this paper
• FOXO1 Couples KGF and PI-3K/AKT Signaling to NKX2.1-Regulated Differentiation of Alveolar Epithelial Cells

  2022cites this paper
• Syndecan-4 affects myogenesis via Rac1-mediated actin remodeling and exhibits copy-number amplification and increased expression in human rhabdomyosarcoma tumors

  2022cites this paper
• Roles of fusion genes in digestive system cancers: dawn for cancer precision therapy.

  2022cites this paper
• The FUS::DDIT3 fusion oncoprotein inhibits BAF complex targeting and activity in myxoid liposarcoma.

  2022cites this paper
• Expanding the spectrum of mesenchymal neoplasms with NR1D1‐rearrangement

  2022cites this paper
• Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe.

  2022cites this paper
• The 3D chromatin landscape of rhabdomyosarcoma

  2022cites this paper
• Clinicopathological Features and Prognostic Factors of Sinonasal Rhabdomyosarcoma

  2022cites this paper
• EphA1 receptor tyrosine kinase is localized to the nucleus in rhabdomyosarcoma from multiple species

  2022cites this paper
• Direct and indirect actions of insulin: role of insulin receptor, glucose transporters (GLUTs), and sodium-glucose linked transporters (SGLTs)

  2022cites this paper
• Molecular Targets for Novel Therapeutics in Pediatric Fusion-Positive Non-CNS Solid Tumors

  2022cites this paper
• Single-cell transcriptomics reveals immune suppression and cell states predictive of patient outcomes in rhabdomyosarcoma

  2022cites this paper
• Neomorphic DNA-binding enables tumor-specific therapeutic gene expression in fusion-addicted childhood sarcoma

  2022cites this paper
• Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors

  2022cites this paper
• Targeting KDM4 for treating PAX3-FOXO1–driven alveolar rhabdomyosarcoma

  2022cites this paper
• Hyalinizing epithelioid tumors with OGT‐FOXO fusions. A case report of a non‐acral soft tissue mass harboring a novel FOXO4 gene rearrangement

  2021cites this paper
• Alveolar rhabdomyosarcoma metastatic to the brain

  2021cites this paper
• The Roles of FOXO1 in Periodontal Homeostasis and Disease

  2021cites this paper
• Energy Metabolism and Ketogenic Diets: What about the Skeletal Health? A Narrative Review and a Prospective Vision for Planning Clinical Trials on this Issue

  2021cites this paper
• Rhabdomyosarcoma: From Obscurity to Clarity in Diagnosis … But With Ongoing Challenges in Management: The Farber-Landing Lecture of 2020

  2021influential citation
• Preclinical In Vivo Modeling of Pediatric Sarcoma—Promises and Limitations

  2021cites this paper
• Role of FoxO transcription factors in aging and age-related metabolic and neurodegenerative diseases

  2021cites this paper
• Diagnosis of soft tissue tumors using immunohistochemistry as a surrogate for recurrent fusion oncoproteins.

  2021cites this paper
• Pioneer factors in development and cancer

  2021cites this paper
• Magnesium demethylcantharidate inhibits hepatocellular carcinoma cell invasion and metastasis via activation transcription factor FOXO1.

  2021cites this paper
• Fusion of the Paired Box 3 (PAX3) and Myocardin (MYOCD) Genes in Pediatric Rhabdomyosarcoma

  2021cites this paper
• Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma

  2021cites this paper
• Gene fusions in vascular tumors and their underlying molecular mechanisms

  2021cites this paper
• Evidence of pioneer factor activity of an oncogenic fusion transcription factor

  2021cites this paper
• Forkhead Box Protein O1: Functional Diversity and Post-Translational Modification, a New Therapeutic Target?

  2021cites this paper
• Differential regulation of autophagy by STAU1 in alveolar rhabdomyosarcoma and non‐transformed skeletal muscle cells

  2021cites this paper
• Rhabdomyosarcoma: How Advanced Molecular Methods Are Shaping the Diagnostic and Therapeutic Paradigm

  2021cites this paper
• Precision medicine in pediatric solid cancers.

  2021cites this paper
• Reduced B7-H3 expression by PAX3-FOXO1 knockdown inhibits cellular motility and promotes myogenic differentiation in alveolar rhabdomyosarcoma

  2021cites this paper
• Integrated diagnosis based on transcriptome analysis in suspected pediatric sarcomas

  2021cites this paper
• Epigenetic Modifications May Regulate the Activation of the Hypopharyngeal Gland of Honeybees (Apis Mellifera) During Winter

  2020cites this paper
• A Review of FoxO1-Regulated Metabolic Diseases and Related Drug Discoveries

  2020cites this paper
• Tissue-Specific Metabolic Regulation of FOXO-Binding Protein: FOXO Does Not Act Alone

  2020cites this paper
• Tumor Suppressors Having Oncogenic Functions: The Double Agents

  2020cites this paper
• Pax9 is essential for granulopoiesis but dispensable for erythropoiesis in zebrafish.

  2020cites this paper
• Synthetic MIR143-3p Suppresses Cell Growth in Rhabdomyosarcoma Cells by Interrupting RAS Pathways Including PAX3–FOXO1

  2020cites this paper
• Survival outcomes of patients with localized FOXO1 fusion‐positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group

  2020cites this paper
• Pathology of childhood rhabdomyosarcoma: A consensus opinion document from the Children's Oncology Group, European Paediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe

  2020cites this paper
• The Application of FOXO1A Expression Predicts Aggressive Behavior and Poor Prognosis in Gliomas

  2020cites this paper
• Therapeutic strategies targeting FOXO transcription factors

  2020cites this paper
• Waardenburg syndrome type 1

  2020cites this paper
• Resveratrol Exerts Anti-Osteoarthritic Effect by Inhibiting TLR4/NF-κB Signaling Pathway via the TLR4/Akt/FoxO1 Axis in IL-1β-Stimulated SW1353 Cells

  2020cites this paper
• A multidisciplinary approach to soft-tissue sarcoma of the extremities

  2020cites this paper
• Tamoxifen induces fatty liver disease in breast cancer through the MAPK8/FoxO pathway

  2020cites this paper
• The role of FOXOs and autophagy in cancer and metastasis—Implications in therapeutic development

  2020cites this paper
• FOXO transcription factor family in cancer and metastasis

  2020cites this paper
• Immune-Based Approaches for the Treatment of Pediatric Malignancies

  2020cites this paper
• Oncogenic role of HMGA2 in fusion-negative rhabdomyosarcoma cells

  2020cites this paper